Is TG Therapeutics Inc halal to invest in?

As of July 2026, TG Therapeutics Inc TGTX is classified as halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.

Is TG Therapeutics Inc a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes TG Therapeutics Inc using these criteria to determine its compliance status.

Can Muslims buy shares of TG Therapeutics Inc?

Muslim investors may consider investing in TG Therapeutics Inc if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is TG Therapeutics Inc classified as HALAL?

Musaffa determines the Shariah status of TG Therapeutics Inc by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for TG Therapeutics Inc updated?

The Shariah compliance status of TG Therapeutics Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like TG Therapeutics Inc become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of TG Therapeutics Inc?

You can check the latest Shariah compliance status of TG Therapeutics Inc on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

TGTX Shariah Compliance

Screening Methodology: AAOIFI

As of July 2026, TG Therapeutics Inc is classified as halal.

HALAL

Report Source: 2026 1st Quarter Report

TG Therapeutics Inc. Stock Analysis TGTX

United States Health Care Mid Cap Report: Q1, 2026

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. The company is headquartered in Morrisville, North Carolina and currently employs 399 full-time employees. Its products include Ublituximab IV (anti-CD20 mAb), Ublituximab IV Simplified Dosing Schedule, Ublituximab Subcutaneous (anti-CD20 mAb), and Azer-cel. The company is engaged in late-stage clinical development of BRIUMVI. BRIUMVI is an anti-CD20 monoclonal antibody that can be administered to adults with relapsing forms of multiple sclerosis (RMS) in a one-hour infusion every 24 weeks, following the starting dose. The company is used for treatment of adults with clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease. The firm is also engaged in ULTIMATE I & II Trials Evaluating Single Agent Ublituximab in RMS. Its ENHANCE Phase 3b Trial is an ongoing, multi-center, open-label study designed to evaluate alternative dosing regimens for BRIUMVI in patients with RMS.

Key Statistics of TG Therapeutics Inc (TGTX)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

$51.28$55.59

Today's Open

$52.26

Volume

1.33M

P/E Ratio (TTM)

18.47

52 Week Range

$25.28$59.30

Market Cap

8.76B

Avg. Volume

2.47M

Dividend Yield

Financial Metrics & Statements of TG Therapeutics Inc (TGTX)

Super Investors Invested in TG Therapeutics Inc (TGTX)

FAQ's for TG Therapeutics Inc (TGTX)

As of July 2026, TG Therapeutics Inc TGTX is classified as halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes TG Therapeutics Inc using these criteria to determine its compliance status.
Muslim investors may consider investing in TG Therapeutics Inc if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
Musaffa determines the Shariah status of TG Therapeutics Inc by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
The Shariah compliance status of TG Therapeutics Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.
Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
You can check the latest Shariah compliance status of TG Therapeutics Inc on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.